arXiv · 2310.18193
Morphology of Vaccine RD&D translation
Abstract
Translation as a concept coordinates participation in innovation but remains a qualitative construct. We provide multivariate accounting of linkages between market entries of vaccines, clinical trials, patents, publications, funders, and grants to quantify biomedical translation. We found that the most prevalent types of biomedical translation are those between basic and applied research (52 percent) followed by those between research and product development (36 percent). Although many biomedical stakeholders assume knowledge flows one way from upstream research to downstream application, knowledge feedbacks that mediate translation are prevalent. We also cluster biomedical funders based on the types of translations they fund. Large-scale funding agencies such as NIH are similarly involved in early-stage translation, whereas pharmaceuticals and mission-oriented agencies such as DARPA involve diverse translation types, and each leaves different translation footprints.
Explore related subjects
Keep this discovery
Martin Ho, Henry CW Price, Tim S Evans, Eoin O'Sullivan. 2023-10-27. Morphology of Vaccine RD&D translation. https://arxiv.org/abs/2310.18193
Cite the original work for its findings. Save a collection to share your selection of sources.